Both in Pharmaceuticals
Unicycive Therapeutics vs Organogenesis Holdings
Over the past year UNCY returned −15.5% and ORGO returned −77.6%; their daily moves had a correlation of 0.09.
UNCY −15.5% ORGO −77.6%Growth of $1, one year, split-adjusted
| Metric | UNCY | ORGO |
|---|---|---|
| Price | $3.75 | $0.8700 |
| Market cap | $104.5M | $111.9M |
| Today | +4.46% | +4.19% |
| 1 month | −11.3% | −35.1% |
| 6 months | −53.9% | −66.0% |
| Year to date | −35.0% | −83.2% |
| 1 year | −15.5% | −78.3% |
| Revenue growth (YoY) | — | −56.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −227.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.2× |
| Net cash | $61.4M | $34.4M |
| Dividend yield | — | — |
| Volatility (60d) | 56.7% | 61.2% |
| Short % of float | 17.8% | 21.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).